🇪🇺 Dihydroartemisinin and piperaquine in European Union

EMA authorised Dihydroartemisinin and piperaquine on 27 October 2011

Marketing authorisation

EMA — authorised 27 October 2011

• Application: EMEA/H/C/001199
• Marketing authorisation holder: Alfasigma S.p.A.
• Local brand name: Eurartesim
• Indication: Eurartesim is indicated for the treatment of uncomplicated Plasmodium falciparum malaria in adults, children and infants 6 months and over and weighing 5 kg or more. Consideration should be given to official guidance on the appropriate use of antimalarial agents.
• Status: approved

Read official source →

Frequently asked questions

Is Dihydroartemisinin and piperaquine approved in European Union?

Yes. EMA authorised it on 27 October 2011.

Who is the marketing authorisation holder for Dihydroartemisinin and piperaquine in European Union?

Alfasigma S.p.A. holds the EU marketing authorisation.